Full access
Clinical and Research News
Published Online: 16 May 2017

How Strong is Link Between Cannabis Use, Mental Health Effects?

Publication: Psychiatrics News
Volume 52, Number 10
https://doi.org/10.1176/appi.pn.2017.5b50
Among the nearly 100 conclusions about the therapeutic benefits and risks of cannabis/cannabinoid use made by the National Academies were numerous findings in the mental health arena. Below are the conclusions that have at least moderate evidence (that is, enough data to make general conclusions, but with enough risk of chance, bias, or confounding factors to not rule out other explanations).
There are enough data to draw firm conclusions of the following, with a limited risk of other explanations due to chance, bias, or confounding factors:
•
Cannabis use is associated with the development of schizophrenia and other psychoses.
•
Starting cannabis use earlier in life increases the risk of problem cannabis use.
•
Stimulant use in teenagers with attention-deficit/hyperactivity disorder (ADHD) is not a risk factor for problem cannabis use.
There is moderate evidence of the following:
•
Cannabis use increases symptoms of mania and hypomania in people with bipolar disorder.
•
Cannabis use is associated with an increased risk of developing depression, and depression is a risk factor for developing problem cannabis use.
•
Cannabis use is associated with increased incidences of suicidal ideation, attempts, and completion.
•
Regular cannabis use is associated with an increased incidence of social anxiety disorder.
•
Anxiety disorders, personality disorders, and bipolar disorder are not risk factors for problem cannabis use.
•
Adolescent ADHD is not a risk factor for problem cannabis use.
•
Problem cannabis use is associated with increased severity of PTSD symptoms. ■

Information & Authors

Information

Published In

Go to Psychiatric News
Psychiatrics News
Volume 52 • Number 10 • May 6, 2017 – May 19, 2017
Pages: 1

History

Published online: 16 May 2017
Published in print: May 6, 2017 – May 19, 2017

Keywords

  1. National Academies
  2. cannabis
  3. cannabinoid
  4. medical marijuana

Authors

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

There are no citations for this item

View Options

View options

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share

×

As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.